Wire · operational-macro
Bemotrizinol Approval: A Step Toward U.S. Sunscreen Modernization
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 20 October 2026 · Fusion42 review
In June 2026, the U.S. FDA approved bemotrizinol as an active ingredient in over-the-counter sunscreens at concentrations up to 6%, the first such monograph update in 27 years and the first via administrative order under the CARES Act.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 3 sources have reported it between 15 Oct 2026 and 20 Oct 2026.
◆ ◆ The Wire takeaway
FDA's approval of bemotrizinol opens a new sunscreen ingredient market that you can enter before competitors update their formulas. Start testing formulations now to capitalise on this rare regulatory opening in sun care products.
◆ Coverage
3 sources · first reported 15 Oct 2026 · latest 20 Oct 2026
◆ Related on Wire
◆ Topics